Guidance
Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) - update 15 March 2022
These are the annexes to WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19. Annexes 1–6 contain tables that summarize the grading of recommendations, assessment, development and evaluations (GRADE). Annexes 7–9 contain the SAGE evidence-to-recommendation framework tables (ETR tables).
GRADE and ETR tables are updated as recommendations are updated.
Version 30 July 2021.
Authors
Languages
- English
Publication year
2021
Type
Guidance
Categories
- Vaccines & delivery devices
Diseases
- COVID-19
Countries
- Chad
Organisations
- World Health Organization (WHO)
